Cardinal Health, McKesson Double Down on CVS Deals Through 2032

Cardinal Health Inc. has entered into a binding Letter of Intent to extend its distribution agreement with CVS Health Inc. through June 30, 2032, reaffirming its fiscal year 2027 adjusted earnings growth guidance of 13% to 15%, equating to $12.40-$12.60 per share. Similarly, McKesson Corporation has signed an agreement to extend its partnership with CVS Health for pharmaceutical distribution until June 2032, maintaining its fiscal 2027 adjusted earnings outlook of $44.20 to $45 per share. Following these announcements, McKesson shares rose by 4.28% to $890.35, while Cardinal Health shares increased by 2.94% to $229.05.